ConductScience.org, home

Disease · MONDO_0006515

Comparisons in its trials17

Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.

ComparisonGroup 1, with the outcomeGroup 2, with the outcomeParticipantsTrialSource
Pentoxifylline vs Placebo: deaths from any cause2 of 450 of 3883NCT02487225Trial comparisons
Pentoxifylline vs Placebo: serious adverse events1 of 450 of 3883NCT02487225Trial comparisons
Neostigmine vs Conservative Treatment: Number of Participants With Adverse Effects on the Cardiovascular System8 of 404 of 4080NCT02543658Trial comparisons
Neostigmine vs Conservative Treatment: New-onset Organ Failure12 of 4016 of 4080NCT02543658Trial comparisons
Neostigmine vs Conservative Treatment: New-onset Abdominal Compartment Syndrom2 of 404 of 4080NCT02543658Trial comparisons
Neostigmine vs Conservative Treatment: Death of 90 Days10 of 4011 of 4080NCT02543658Trial comparisons
Neostigmine vs Conservative Treatment: Number of Participants With Deterioration of IAH4 of 408 of 4080NCT02543658Trial comparisons
Neostigmine vs The Traditional Treatment: deaths from any cause10 of 4011 of 4080NCT02543658Trial comparisons
Neostigmine vs The Traditional Treatment: serious adverse events8 of 404 of 4080NCT02543658Trial comparisons
Indomethacin Suppository vs Placebo: Mortality0 of 181 of 2442NCT02692391Trial comparisons
Indomethacin Suppository vs Placebo: Number of Participants Who Development of Organ Failure3 of 186 of 2442NCT02692391Trial comparisons
Indomethacin Suppository vs Placebo: deaths from any cause0 of 181 of 2442NCT02692391Trial comparisons
Indomethacin Suppository vs Placebo: serious adverse events0 of 180 of 2442NCT02692391Trial comparisons
Pentoxifylline vs Placebo: Number Of Subjects With New Onset Pancreatic Necrosis During Hospitalization0 of 142 of 1428NCT01292005Trial comparisons
Pentoxifylline vs Placebo: Number Of Subjects With New Onset Organ Failure During Hospitalization0 of 143 of 1428NCT01292005Trial comparisons
Pentoxifylline vs Placebo: Number of Subjects Who Needed an Intensive Care Unit Stay0 of 144 of 1428NCT01292005Trial comparisons
Pentoxifylline vs Placebo: serious adverse events0 of 140 of 1428NCT01292005Trial comparisons

diseases-2026-09-18-0.1.0

Sources 6

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • NLM's MeSHNLM's terms
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • NLM's MeSHNLM's
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/diseases/v1/MONDO_0006515/comparisons